KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance
Gross profit increased $1.3 million or 8.7% for the year ended December 31, 2023, compared to the same period in 2022.
- Gross profit increased $1.3 million or 8.7% for the year ended December 31, 2023, compared to the same period in 2022.
- Allowing for a one-time inventory adjustment for a product discontinuation, adjusted gross margin for the year ended 2023 was 59.6%.
- This new debt facility provides KORU Medical with additional capital flexibility to support a reserve for growth and strategic opportunities.
- Non-GAAP financial measures are meant to supplement, and to be viewed in conjunction with, GAAP financial results.